QUOTE AND NEWS
Benzinga  May 27  Comment 
Costco Wholesale Corporation (NASDAQ: COST) is all set to report its quarterly earnings following the closing bell on Wednesday. Brian Nagel, senior analyst at Oppenheimer & Co, was on CNBC recently to discuss how much impact oil prices will have...
Benzinga  May 22  Comment 
In separate reports published Friday, Oppenheimer analysts initiated coverage of two gene therapy stocks - Cellectis SA (NASDAQ: CLLS) and Uniqure NV (NASDAQ: QURE) - with an Outperform rating. The price target for Cellectis is at $65, while that...
Benzinga  May 21  Comment 
In a report published Thursday, Oppenheimer analysts reiterated their Buy rating and price target of $155 on Apple Inc. (NASDAQ: AAPL). The analysts believe that investor concerns regarding the company's declining growth are premature for...
Yahoo  May 20  Comment 
Discussing whether Apple has cannibalized retail stores, with Brian Nagel, Oppenheimer, and the FM traders,
Benzinga  May 19  Comment 
In a new report, analysts at Oppenheimer laid out their bullish case for Palo Alto Networks Inc (NYSE: PANW) based on their most recent round of channel checks. The report includes several reasons why analysts believe that Palo Alto’s stock...
TheStreet.com  May 18  Comment 
NEW YORK (TheStreet) -- The shares of action camera maker GoPro  are climbing after Oppenheimer upgraded the stock to Perform from Underperform, saying that the company's shipments are poised to continue to increase this year. WHAT'S NEW:...
Benzinga  May 18  Comment 
In a report published Monday, Oppenheimer analysts maintained an Outperform rating on Yum! Brands, Inc. (NYSE: YUM), while raising the price target from $90 to $105, saying they were now "more excited that fundamental upside lingers." The...
Benzinga  May 15  Comment 
In a report published Friday, Oppenheimer analysts initiated coverage on Five Prime Therapeutics Inc (NASDAQ: FPRX) with an Outperform rating and a price target of $45. Five Prime Therapeutics is a biotech company engaged in developing a...
Benzinga  May 14  Comment 
Crude oil has seen a massive recovery from mid-$40 levels just two months ago to above $60 where it is trading now. While some are bullish that this move will continue and prices will continue to move upwards till $100, Oppenheimer Energy analyst...
Benzinga  May 14  Comment 
In a report published Thursday, Oppenheimer analysts upgraded the rating on Ctrip.com International, Ltd (NASDAQ: CTRP) from Perform to Outperform, with a price target of $80, after the company exhibited strong revenue momentum. The analysts...





You may also be interested in articles related to Oppenheimer Holdings (OPY):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki